Sensoril® Ashwagandha is Among Kerry’s Portfolio of Solutions Tailored to Meet Women’s Unique Health Needs
Kerry Group, a global leader in taste and nutrition solutions, is further strengthening its offering for women’s health, with a new clinical study showing that Kerry’s Sensoril® ashwagandha supports quality of life for women post menopause.
The recently published study validates Sensoril’s unique ability to support symptom management and quality of life in women post menopause, at as low as 250mg/day. This research builds on fourteen previous scientific studies proving the natural ingredient is a safe and effective solution to support overall health. Kerry’s deep commitment to meeting women’s distinctive health needs proves the company is an ideal partner in creating science-backed products that can have a positive impact on the lives of women globally.
Hormonal changes associated with menopause can lead to negative symptoms like hot flashes, mood swings, and sleep disturbances. Approximately 80% of women experience these symptoms, making it a common but typically overlooked or ignored aspect of women’s health.1 Despite the frequency of these symptoms, the impact of menopause on ageing, has not been considered widely in research, leading to gaps in healthcare.2 With one billion women estimated to be experiencing menopause in 2025, these shortcomings must be addressed.3
“Women are looking for a proactive approach to wellbeing, where their specific health needs are understood and met with the right product at the right time, and Kerry is rising to the occasion,” said Dr. Monica Maria Olivares, RDA Director of Women’s & Infant Health at Kerry. “This study further supports the current and extensive research naming Sensoril a safe and effective solution. Driving progress in women’s health is of vital importance to us at Kerry, which is why we have curated a suite of naturally sourced and clinically studied ingredients that support women across every life stage. ”
Participants in the study self-reported decreases across key known menopause symptoms, including:
- 24% decrease in presence and severity of vasomotor symptoms such as hot flashes, sweating, and night sweats.
- 16% decrease in presence and severity of psychosocial symptoms such as poor memory, anxious feelings, lower productivity, dissatisfaction with personal life, and more.
- 14% decrease in presence and severity of physical symptoms related to sleep, fatigue, strength, stamina, energy, appearance, aches and pains, and more.
- 13% decrease in presence and severity of issues related to sexual health, such as intimacy avoidance.
The use of herbal, plant-based treatments for managing menopausal symptoms has gained popularity as many women seek more natural alternatives to hormone replacement therapy. Sensoril, a unique, standardized, synergetic combination of the ashwagandha root and leaf, directly meets these growing consumer desires. As women take control of their health, it’s critical that innovators provide product formats which not only offer support, but also encourage habitual intake, alleviating the burden often associated with supplements. With proven efficacy, Sensoril can be a key, natural ingredient integrated into solutions specifically targeted toward women.
As part of a broader focus on women’s health, Kerry launched HerWay, an online resource addressing women’s unique health and wellness experiences. HerWay houses key information on pressing health and wellness issues, as well as news regarding the latest market trends in women’s health. Supplement and formula manufacturers interested in learning more or partnering with Kerry can explore options to aid in supporting at supplements.kerry.com.
1. Exploring Women´s Health: Breaking Taboos in Menopause. Euromonitor. Feb 2021
2. https://hms.harvard.edu/news/how-gaps-scientific-data-lead-gaps-care-aging-women
3. Shifren, J. L., & Gass M. L. S., NAMS Recommendations for Clinical Care of Midlife Women Working Group. (2014). The North American Menopause Society recommendations for clinical care of midlife women. Menopause, 21(10), 1-25. (The North American Menopause Society recommendations for clinical care of midlife women – PubMed
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
